Cytotoxicity of chlorhexidine on human osteoblastic cells is related to intracellular glutathione levels

被引:58
|
作者
Lee, T. -H. [1 ,2 ]
Hu, C. -C. [3 ]
Lee, S. -S. [4 ]
Chou, M. -Y. [5 ]
Chang, Y. -C. [2 ,5 ]
机构
[1] Chung Shan Med Univ, Inst Med, Taichung, Taiwan
[2] Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan
[3] Chung Shan Med Univ, Sch Appl Chem, Taichung, Taiwan
[4] Chung Shan Med Univ, Sch Publ Hlth, Taichung, Taiwan
[5] Chung Shan Med Univ, Sch Dent, Taichung, Taiwan
关键词
chlorhexidine; cytotoxicity; glutathione; osteoblastic cells; FIBROBLASTS IN-VITRO; CALCIUM HYDROXIDE; ENTEROCOCCUS-FAECALIS; GLUCONATE; MECHANISMS; THERAPY; IODINE;
D O I
10.1111/j.1365-2591.2010.01700.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
P>Aim To evaluate the mechanisms of cytotoxicity of chlorhexidine (CHX) in human osteoblastic cells in vitro. Methodology Cytotoxicity, cell proliferation and collagen synthesis assays were performed to elucidate the toxic effects of CHX on the human osteoblastic cell line U2OS. To determine whether glutathione (GSH) levels were important in the cytotoxicity of CHX, cells were pre-treated with 2-oxothiazolidine-4-carboxylic acid (OTZ) to boost GSH levels or buthionine sulfoximine (BSO) to deplete GSH. Results CHX demonstrated a cytotoxic effect to U2OS cells in a dose-dependent manner (P < 0.05). The 50% inhibition concentration of CHX was approximately 0.005%. CHX also inhibited cell proliferation and collagen synthesis (P < 0.05). The addition of OTZ acted as a protective effect on the CHX-induced cytotoxicity (P < 0.05). In contrast, the addition of BSO enhanced the CHX-induced cytotoxicity (P < 0.05). Conclusions The levels of CHX tested inhibited cell growth, proliferation and collagen synthesis on U2OS cells. CHX has significant potential for periapical toxicity. GSH depletion might be one of the mechanisms underlying CHX cytotoxicity.
引用
收藏
页码:430 / 435
页数:6
相关论文
共 50 条
  • [31] Intracellular Glutathione: A main factor for TEGDMA-induced cytotoxicity?
    Martins, Alberici C.
    Leyhausen, G.
    Geurtsen, W.
    Volk, J.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2011, 383 : 86 - 87
  • [32] INTRACELLULAR LEVELS OF GLUTATHIONE AND REDUCED GLUTATHIONE AND THEIR RELATION TO GLUTATHIONE TRANSPORT ACROSS THE CANALICULAR OR SINUSOIDAL MEMBRANE IN RAT-LIVER CELLS
    AKERBOOM, TPM
    GARTNER, M
    SIES, H
    HOPPE-SEYLERS ZEITSCHRIFT FUR PHYSIOLOGISCHE CHEMIE, 1981, 362 (03): : 189 - 189
  • [33] Intracellular glutathione: A main factor in TEGDMA-induced cytotoxicity?
    Martins, Caroline Alberici
    Leyhausen, Gabriele
    Geurtsen, Werner
    Volk, Joachim
    DENTAL MATERIALS, 2012, 28 (04) : 442 - 448
  • [34] INCREASED INTRACELLULAR GLUTATHIONE LEVELS PROTECT HUMAN T-LEUKEMIA-CELLS FROM FAS-MEDIATED APOPTOSIS
    CHIBA, T
    TAKAHASHI, S
    OGURIHYAKUMACHI, N
    SAHARA, H
    SATO, N
    KIKUCHI, K
    FASEB JOURNAL, 1995, 9 (03): : A523 - A523
  • [35] INTRACELLULAR GLUTATHIONE LEVELS IN HUMAN-COLON CANCER-CELLS NATURALLY RESISTANT TO CROSS-LINKING AGENTS
    OZAWA, S
    IWATA, K
    KUBODERA, A
    INABA, M
    JOURNAL OF PHARMACOBIO-DYNAMICS, 1989, 12 (07): : 378 - 383
  • [36] Intracellular glutathione regulates Andrographolide-induced cytotoxicity on hepatoma Hep3B cells
    Ji, Lili
    Shen, Kaikai
    Liu, Jun
    Chen, Ying
    Liu, Tianyu
    Wang, Zhengtao
    REDOX REPORT, 2009, 14 (04) : 176 - 184
  • [37] In vitro effect of glutathione precursors on cytotoxicity of amino acids to human mesothelial cells
    Grzybowski, AE
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1999, 50 (03): : 463 - 475
  • [38] Intracellular distribution of the lysyl oxidase propeptide in osteoblastic cells
    Guo, Ying
    Pischon, Nicole
    Palamakumbura, Amitha H.
    Trackman, Philip C.
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2007, 292 (06): : C2095 - C2102
  • [39] Glycodynamics of human osteoblastic cells
    Brockhausen, I
    Yang, XJ
    Harrison, M
    GLYCOBIOLOGY, 2005, 15 (11) : 1242 - 1242
  • [40] Elevated intracellular glutathione levels in CD4(+) T cells of BB rats
    Groen, H
    Pater, JM
    Nieuwenhuis, P
    Rozing, J
    TRANSPLANTATION PROCEEDINGS, 1997, 29 (03) : 1679 - 1680